Global Ascites Market – Industry Trends and Forecast to 2029

Ascites Market??????? Analysis and Size

Ascites may be caused by hypothyroidism, nephritic syndrome, and ovarian disorders in women. This condition often manifest as nausea, heartburn, stomach discomfort, vomiting, shortness of breath, and an enlarged belly. The major market players are focusing persistently on research and development activities that have led to innovations and novel product launches which have contributed to the growth of the ascites market.

Data Bridge Market Research analyses a growth rate in the global ascites market in the forecast period 2022-2029. The expected CAGR of global ascites market is tend to be around 4.50% in the mentioned forecast period. The market was valued at USD 2.39 billion in 2021, and it would grow upto USD 3.40 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Ascites Market Scope and Segmentation

Market Definition

Ascites is the condition wherein an abnormal accumulation of fluid occurs within the peritoneal cavity. It usually occurs because of liver malfunctions; when the liver stops working properly or fluid fills the space between the abdominal lining and other organs. Several patients suffering from liver cirrhosis, stomach cancer, congestive heart failure or tuberculosis are at major risk of getting ascites. This disease prevalence is rising and important diagnostic procedures and treatments will boost the growth of the market.

Global Ascites Market Dynamics

Drivers

• Increased Rate of Ovarian Cancer

Ovarian cancer ranks fifth in women's cancer deaths, resulting in more deaths than any other cancer. Any female having the risk of getting ovarian cancer during her lifetime is around 1 in 78. According to the data published by National Cancer Institute, around 1.3% of women will be diagnosed with ovarian cancer at some point in their lifetime. Thus boosting the market growth.

• Higher Rate of Drug Approvals and Launches       

An extensive range of new generation therapeutics targets, including novel small molecules and cellular therapy, are currently under process. These include mongersen, tofacitinib, ustekinumab, and vedolizumab. This influx is expected to be a consequence of rising prevalence of gastrointestinal diseases worldwide. In addition to this, drugs also form the first line of treatment in ascites management and in the coming future, strong drug pipeline is expected to provide highly effective drug molecule. Thus, all these developments are boosting the growth of the market.

Opportunities

• High-end Efficiency of Biologics

Some studies have stated that biologics show greater long-term efficiency. According to a study which University of Chicago conducted, it was witnessed that the usage of biologics has resulted in a complete decrease in the number of surgeries by about 40.0%, emergency room visits by 60.0%, and hospitalizations by 50.0%. All these factors are also contributing in the growth of the market.  

• The Wide Application of Generic Drugs

Branded drug manufacturers and generic producing firms are joining up together for the production of generic drugs after patent expiry, which is projected to lift the growth of generics. In addition, major firms are gradually focusing on developing generics due to the increase in off-patented drugs in the market. Although, marketing exclusivity given by the FDA to patent holders for several indications is predicted to hamper market growth to a slight extent.

Restraints/Challenges

• Higher Expenditure Associated With Ascites Treatment

High-end expenditure regarding the drug manufacturing and development process are hampering the market's growth. High initial investment required in the R&D activities for developing vaccines, drugs, and kits used in the treatment are restraining growth of the global ascites market.

• Unavailability of Appropriate Treatments

To treat conditions which are rare, many a times all treatments are not available, especially in under-developed countries. The severe patients needs to be treated with the advanced techniques but at times, these are not available in the hospitals and clinics. Thus, it hampers the market growth.

This global ascites market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global ascites market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Ascites Market Scope

The global ascites market is segmented on the basis of types, diagnosis, treatment, route of administration,end-user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Types

• Transudative
• Exudative
• Others

Diagnosis

• Ultrasound
• CT Scan
• MRI
• Blood Test
• Laparoscopy
• Angiography
• Others

Treatment

• Medication
• Paracentesis
• Surgery
• Others 

Route of Administration

• Oral
• Parenteral
• Others

End-Users

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacies
• Others

Ascites Market Regional Analysis/Insights

The global ascites market is analyzed and market size insights and trends are provided by types, diagnosis, treatment, route of administration,end-user, distribution channel as referenced above.

The major countries covered in the global ascites market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is considered to have the highest lucrative growth in the forecast period due to the presence of key manufacture of the product, high research & development, healthcare expenditure, and skilled professionals.

Asia-Pacific dominates the market due to increased government awareness programs, increased prevalence of kidney failure and tuberculosis and the presence of the generic manufacturer.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Ascites Market Share Analysis

The global ascites market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global ascites market.

Key players operating in the global ascites market include:

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Sanofi (France)
• Pfizer Inc. (U.S.)
• GSK plc (U.K.)
• Novartis AG (Switzerland)
• AstraZeneca (U.K.)
• Johnson & Johnson Private Limited (U.S.)
• Sun Pharmaceutical Industries Ltd. (India)
• Merck & Co., Inc. (U.S.)
• Lilly (U.S.)
• WOCKHARDT (India)

SKU-55200